Long-term effects of pioglitazone versus gliclazide on insulin sensitivity and lipids in patients with type 2 diabetes

被引：0
|
作者：
Charbonnel, B
Roden, M
Urquhart, R
Mariz, S
Edwards, G
Johns, D
Widel, M
Mihm, M
Tan, M
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A121 / A121
页数：1
相关论文
共 50 条
  • [1] Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes
    Betteridge, DJ
    Vergès, B
    DIABETOLOGIA, 2005, 48 (12) : 2477 - 2481
  • [2] Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes
    D. J. Betteridge
    B. Vergès
    Diabetologia, 2005, 48 : 2477 - 2481
  • [3] Long-term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus
    Roden, M
    Laakso, M
    Johns, D
    Widel, M
    Urquhart, R
    Richardson, C
    Mariz, S
    Tan, MH
    DIABETIC MEDICINE, 2005, 22 (08) : 1101 - 1106
  • [4] Pioglitazone elicits long-term improvements in insulin sensitivity in patients with type 2 diabetes: comparisons with gliclazide-based regimens
    B. Charbonnel
    M. Roden
    R. Urquhart
    S. Mariz
    D. Johns
    M. Mihm
    M. Widel
    M. Tan
    Diabetologia, 2005, 48 : 553 - 560
  • [5] Pioglitazone elicits long-term improvements in insulin sensitivity in patients with type 2 diabetes: comparisons with gliclazide-based regimens
    Charbonnel, B
    Roden, M
    Urquhart, R
    Mariz, S
    Johns, D
    Mihm, M
    Widel, M
    Tan, M
    DIABETOLOGIA, 2005, 48 (03) : 553 - 560
  • [6] Long-term efficacy and safety of pioglitazone in comparison to gliclazide in patients with Type 2 diabetes
    Perriello, G
    Pampanelli, S
    Di Pietro, C
    Rinaldi, T
    Brunetti, P
    DIABETOLOGIA, 2004, 47 : A261 - A261
  • [7] Long-term (2-year) effects on serum lipids of pioglitazone, gliclazide and metformin as add-on therapies in patients with Type 2 diabetes
    Mariz, S
    Tan, MH
    Moules, I
    Edwards, G
    Urquhart, R
    DIABETOLOGIA, 2004, 47 : A261 - A262
  • [8] Effect of pioglitazone versus gliclazide on serum lipids over two years in patients with Type 2 diabetes
    Johns, D
    Mattoo, V
    Urquhart, R
    Voet, B
    Mariz, S
    Tan, M
    DIABETOLOGIA, 2004, 47 : A410 - A410
  • [9] THE LONG-TERM EFFECTS OF GLICLAZIDE ON MUSCLE INSULIN SENSITIVITY IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS
    JOHNSON, A
    THOW, J
    ARGYRAKI, M
    MILLER, M
    BROUGHTON, D
    JONES, IR
    TAYLOR, R
    DIABETOLOGIA, 1988, 31 (07) : A505 - A505
  • [10] THE EFFECTS OF LONG-TERM GLICLAZIDE ADMINISTRATION ON INSULIN-SECRETION AND INSULIN SENSITIVITY
    MA, A
    KAMP, M
    BIRD, D
    HOWLETT, V
    CAMERON, DP
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1989, 19 (01): : 44 - 49
12345